Sfoglia per AUTORE
PERINI P
Collezione AOU San Luigi di Orbassano

  

Items : 16

Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle Project. in Neurology and therapy / Neurol Ther. 2024 Oct;13(5):1415-1430. doi: 10.1007/s40120-024-00644-3. Epub 2024 Aug 2.
2024
AOU San Luigi di Orbassano

Paolicelli D; Borriello G; Clerici R; Colombo E; Croce D; D'Amico E; De Rossi N; Di Sapio A; Fenu G; Maimone D; Marfia GA; Moccia M; Perini P; Piscaglia MG; Razzolini L; Riccaboni M; Signoriello E; Agostoni G; Farina A; Mondino M; Berruto F; Tettamanti A; Donnaloja F; Tortorella C;

Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study. in Journal of neurology / J Neurol. 2023 Oct;270(10):4687-4696. doi: 10.1007/s00415-023-11820-0. Epub 2023 Jul 5.
2023
AOU San Luigi di Orbassano

Amato MP; Bergamaschi R; Centonze D; Mirabella M; Marfia GA; Totaro R; Lus G; Brescia Morra V; Aguglia U; Comi C; Cavalla P; Zaffaroni M; Rovaris M; Grimaldi LM; Leoni S; Malucchi S; Baldi E; Romano M; Falcini M; Perini P; Assetta M; Portaccio E; Sommacal S; Olivieri N; Parodi F; Todaro DS; Grassivaro N; Farina A; Mondino MM; et alii...

Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2023 Feb;70:104474. doi: 10.1016/j.msard.2022.104474. Epub 2022 Dec 19.
2023
AOU San Luigi di Orbassano

Patti F; Chisari CG; Toscano S; Annovazzi P; Banfi P; Bergamaschi R; Clerici R; Conti MZ; Cortese A; Fantozzi R; Ferraro D; Fischetti M; Frigo M; Gatto M; Immovilli P; Leoni S; Malucchi S; Maniscalco G; Marfia GA; Paolicelli D; Perini P; Serrati C; Totaro R; Turano G; Valentino P; Zaffaroni M; Zuliani C; Centonze D; Patti F; et alii...

A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2022 Jul;63:103909. doi: 10.1016/j.msard.2022.103909. Epub 2022 May 25.
2022
AOU San Luigi di Orbassano

Ponzano M; Schiavetti I; Bovis F; Landi D; Carmisciano L; De Rossi N; Cordioli C; Moiola L; Radaelli M; Immovilli P; Capobianco M; Bragadin MM; Cocco E; Scandellari C; Cavalla P; Pesci I; Confalonieri P; Perini P; Bergamaschi R; Inglese M; Petracca M; Trojano M; Tedeschi G; Comi G; Battaglia MA; Patti F; Fragoso YD; Sen S; Siva A; et alii...

COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2021 Nov 9;9(1):e1105. doi: 10.1212/NXI.0000000000001105. Print 20
2022
AOU San Luigi di Orbassano

Sormani MP; Schiavetti I; Carmisciano L; Cordioli C; Filippi M; Radaelli M; Immovilli P; Capobianco M; De Rossi N; Brichetto G; Cocco E; Scandellari C; Cavalla P; Pesci I; Zito A; Confalonieri P; Marfia GA; Perini P; Inglese M; Trojano M; Brescia Morra V; Tedeschi G; Comi G; Battaglia MA; Patti F; Salvetti M; Sormani MP; Schiavetti I; Carmisciano L; et alii...

The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis. in European journal of neurology / Eur J Neurol. 2022 Feb;29(2):535-542. doi: 10.1111/ene.15167. Epub 2021 Nov 15.
2022
AOU San Luigi di Orbassano

Tedeschi G; Pisoni E; Brescia Morra V; Trojano M; Inglese M; Perini P; Marfia GA; Confalonieri P; Zito A; Cavalla P; Pesci I; Scandellari C; Cocco E; Brichetto G; De Rossi N; Capobianco M; Immovilli P; Radaelli M; Filippi M; Carmisciano L; Cordioli C; Schiavetti I; Ponzano M; Bergamaschi R; Comi G; Battaglia MA; Patti F; Salvetti M; Sormani MP; et alii...

Signs and symptoms of COVID-19 in patients with multiple sclerosis. in European journal of neurology / Eur J Neurol. 2022 Dec;29(12):3728-3736. doi: 10.1111/ene.15554. Epub 2022 Sep 23.
2022
AOU San Luigi di Orbassano

Schiavetti I; Carmisciano L; Ponzano M; Cordioli C; Cocco E; Marfia GA; Inglese M; Filippi M; Radaelli M; Bergamaschi R; Immovilli P; Capobianco M; De Rossi N; Brichetto G; Scandellari C; Cavalla P; Pesci I; Confalonieri P; Perini P; Trojano M; Lanzillo R; Tedeschi G; Comi G; Battaglia MA; Patti F; Salvetti M; Sormani MP;

Multiple sclerosis epidemiological trends in Italy highlight the environmental risk factors. in Journal of neurology / J Neurol. 2022 Apr;269(4):1817-1824. doi: 10.1007/s00415-021-10782-5. Epub 2021 Sep 27.
2022
AOU San Luigi di Orbassano

Puthenparampil M; Perini P; Bergamaschi R; Capobianco M; Filippi M; Gallo P; Puthenparampil M; Perini P; Bergamaschi R; Capobianco M; Filippi M; Gallo P;

Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study. in Journal of neurology / J Neurol. 2021 Aug;268(8):2922-2932. doi: 10.1007/s00415-021-10455-3. Epub 2021 Feb 22.
2021
AOU San Luigi di Orbassano

Bucello S; Annovazzi P; Ragonese P; Altieri M; Barcella V; Bergamaschi R; Bianchi A; Borriello G; Buscarinu MC; Callari G; Capobianco M; Capone F; Cavalla P; Cavarretta R; Cortese A; De Luca G; Di Filippo M; Dattola V; Fantozzi R; Ferraro E; Filippi MM; Gasperini C; Grimaldi LME; Landi D; Re ML; Mallucci G; Manganotti P; Marfia GA; Mirabella M; et alii...

Cladribine vs other drugs in MS: Merging randomized trial with real-life data. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2020 Aug 14;7(6):e878. doi: 10.1212/NXI.0000000000000878. Print 20
2020
ASL Cuneo 1
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sormani MP; Visconti A; Landi D; Ippolito D; Esposito S; Russo CV; Barrilà C; Barone S; Grasso R; Pontecorvo S; Di Sapio A; Stromillo ML; Cordioli C; Rasia S; Sartori A; Clerici VT; Fenu G; Cocco E; Frau J; Barcella V; Frigeni B; La Gioia S; Pareja-Gutierrez L; Laroni A; Zarbo IR; Lavorgna L; Bonavita S; Perini P; Mataluni G; et alii...

First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2020 Jul;42:102059. doi: 10.1016/j.msard.2020.102059. Epub 2020 Mar 16.
2020
ASL Cuneo 1
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Signori A; Sormani MP; Carmisciano L; Turano G; Ippolito D; Russo CV; Frigeni B; Landi D; Barrilà C; Barone S; Lavorgna L; Grasso R; Di Sapio A; Cerqua R; Pontecorvo S; Stromillo ML; Cordioli C; Signoriello E; Rasia S; Sartori A; Zarbo IR; Laroni A; Frau J; Cocco E; Torri Clerici V; La Gioia S; Gutierrez LP; Clerico M; Mataluni G; et alii...

Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study). in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2020 Jul;42:102124. doi: 10.1016/j.msard.2020.102124. Epub 2020 Apr 13.
2020
AOU San Luigi di Orbassano

Patti F; Chisari CG; D'Amico E; Annovazzi P; Banfi P; Bergamaschi R; Clerici R; Conti MZ; Cortese A; Fantozzi R; Fischetti M; Frigo M; Gatto M; Immovilli P; Leoni S; Malucchi S; Maniscalco G; Marfia GA; Paolicelli D; Perini P; Serrati C; Sola P; Totaro R; Turano G; Valentino P; Zaffaroni M; Zuliani C; Centonze D;

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study. in Journal of neurology / J Neurol. 2018 Dec;265(12):2851-2860. doi: 10.1007/s00415-018-9070-x. Epub 2018 Sep 26.
2018
AOU San Luigi di Orbassano

Prosperini L; Annovazzi P; Boffa L; Buscarinu MC; Gallo A; Matta M; Moiola L; Musu L; Perini P; Avolio C; Barcella V; Bianco A; Farina D; Ferraro E; Pontecorvo S; Granella F; Grimaldi LME; Laroni A; Lus G; Patti F; Pucci E; Pasca M; Sarchielli P;

Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study. in Journal of neurology / J Neurol. 2018 Aug;265(8):1850-1859. doi: 10.1007/s00415-018-8916-6. Epub 2018 Jun 14.
2018
AOU San Luigi di Orbassano

Mallucci G; Annovazzi P; Miante S; Torri-Clerici V; Matta M; La Gioia S; Cavarretta R; Mantero V; Costantini G; D'Ambrosio V; Zaffaroni M; Ghezzi A; Perini P; Rossi S; Bertolotto A; Rottoli MR; Rovaris M; Balgera R; Cavalla P; Montomoli C; Bergamaschi R;

Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study. in Journal of neurology / J Neurol. 2016 Sep;263(9):1727-35. doi: 10.1007/s00415-016-8188-y. Epub 2016 Jun 10.
2016
AOU San Luigi di Orbassano

Moiola L; Annovazzi P; Capobianco M; Patti F; Frau J; Uccelli A; Centonze D; Perini P; Tortorella C; Prosperini L; Lus G; Fuiani A; Falcini M; Martinelli V; Comi G; Ghezzi A;

Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study. in Expert opinion on drug delivery / Expert Opin Drug Deliv. 2016 Jun;13(6):799-805. doi: 10.1517/17425247.2016.1158161. Epub 2016 Mar 12
2016
AOU San Luigi di Orbassano

Paolicelli D; Cocco E; Di Lecce V; Direnzo V; Moiola L; Lanzillo R; Perini P; Malucchi S; Borriello G; Portaccio E; Panetta V; Fenu G; Sangalli F; Cacciaguerra L; Trojano M;